Humana Inc. (NYSE:HUM) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its stake in Humana Inc. (NYSE:HUM) by 0.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,832 shares of the insurance provider’s stock after selling 128 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Humana were worth $9,303,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. First Financial Corp IN raised its position in Humana by 7.2% in the fourth quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after purchasing an additional 23 shares during the period. Aurora Investment Counsel boosted its position in shares of Humana by 1.3% during the fourth quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock worth $1,155,000 after buying an additional 29 shares during the period. Signaturefd LLC grew its stake in shares of Humana by 1.2% in the fourth quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock valued at $1,206,000 after buying an additional 30 shares in the last quarter. Brighton Jones LLC raised its holdings in shares of Humana by 6.8% in the 4th quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock valued at $215,000 after buying an additional 30 shares during the period. Finally, OneAscent Financial Services LLC lifted its stake in Humana by 7.7% during the 4th quarter. OneAscent Financial Services LLC now owns 477 shares of the insurance provider’s stock worth $218,000 after acquiring an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE HUM traded up $11.39 during trading hours on Tuesday, hitting $395.60. The company had a trading volume of 1,553,529 shares, compared to its average volume of 1,771,052. The business has a 50 day moving average of $358.11 and a 200-day moving average of $346.61. The company has a market cap of $47.67 billion, a PE ratio of 24.63, a price-to-earnings-growth ratio of 2.21 and a beta of 0.51. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business’s revenue was up 10.7% on a year-over-year basis. During the same period in the prior year, the firm earned $9.38 EPS. As a group, equities research analysts expect that Humana Inc. will post 16.27 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is currently 22.04%.

Analyst Ratings Changes

HUM has been the subject of several recent research reports. Piper Sandler initiated coverage on shares of Humana in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price objective for the company. UBS Group dropped their price target on shares of Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a research note on Thursday, April 25th. Jefferies Financial Group reduced their price objective on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Oppenheimer decreased their target price on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a report on Thursday, April 25th. Finally, Robert W. Baird initiated coverage on Humana in a report on Thursday, May 30th. They set a “neutral” rating and a $374.00 price target on the stock. Fourteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus price target of $402.05.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.